PCRXPacira BioSciences, Inc.

$971M

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$542M+26.0% YoY

Gross Profit

$401M74.1% margin

Operating Income

$90M16.6% margin

Net Income

$42M7.8% margin

EPS (Diluted)

$0.92

Cash Flow

Operating Cash Flow

$126M

Free Cash Flow

$80M

Stock-Based Comp.

$42M

Balance Sheet

Total Assets

$2.1B

Total Liabilities

$1.3B

Stockholders' Equity

$730M

Cash & Equivalents

$586M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$542M	$430M	+26.0%
Gross Profit	$401M	$312M	+28.5%
Operating Income	$90M	$46M	+94.0%
Net Income	$42M	$146M	-71.2%

PCRX FY 2021 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena